#genentech — Public Fediverse posts

https://www.europesays.com/ch/120054/ Roche Pays $190M Upfront for Hanmi’s First-in-Class Obesity Drug — BigGo Finance #BorisZaïtra #CarmotTherapeutics #EliLilly #Genentech #HanmiPharm #HM17321 #InYoungChoi #Roche

https://www.europesays.com/ch/119922/ Roche outlays $2.3bn for Hanmi’s non-GLP-1 obesity candidate #ClinicalTrials #development #Genentech #Hanmi #HanmiPharm #LicensingAgreement #MuscleAtrophy #Obesity #PhaseIClinicalTrial #Roche #WeightLoss

https://www.europesays.com/ch/119550/ James Sabry takes over global partnering for Roche #biotech #BusinessDevelopment #Genentech #Partnerships #Roche

https://www.europesays.com/ch/119228/ Roche’s US subsidiary Genentech announces manufacturing expansion in the United States #DrugDeliveryDevices #FlexibleManufacturing #Genentech #HollySprings #Manufacturing #ManufacturingFacility #ManufacturingJobs #NorthCarolina #Roche #RocheGroup

https://www.europesays.com/ch/118515/ Roche commits $750m to double Oregon-based US manufacturing capacity #Genentech #Manufacturing #Oregon #Roche

https://www.europesays.com/ch/118149/ Roche’s US subsidiary Genentech announces manufacturing expansion in the United States #DrugDeliveryDevices #FlexibleManufacturing #Genentech #HollySprings #Manufacturing #ManufacturingFacility #ManufacturingJobs #NorthCarolina #Roche #RocheGroup

https://www.europesays.com/ch/118127/ Roche earmarks $750M to double the size of its Oregon manufacturing facility #AsepticFilling #DrugManufacturing #FiercePharmaHomepage #Genentech #Manufacturing #Roche

https://www.europesays.com/ch/115356/ Roche’s Tecentriq nabs ctDNA-guided bladder cancer nod #FiercePharmaHomepage #Genentech #Natera #Pharma #Roche #Tecentriq

https://www.europesays.com/ch/115027/ Genentech, Novartis accused of Xolair kickback scheme in lawsuit #FalseClaimsAct #FiercePharmaHomepage #Genentech #lawsuit #Novartis #Pharma #Xolair

Jason Coloma: The FTC Killed Our Sanofi Deal. Six Months Later, We Had a Better One. — BigGo Finance

The Federal Trade Commission does not usually feature prominently in a biotech CEO’s business plan. For Jason Coloma,…
#France #FR #Europe #EU #Sanofi #APOL1 #AstraZeneca #BridgeBio #FTC #Genentech #JasonColoma #MazeTherapeutics #Parasol(UniversityofMichigan) #Pompedisease #Roche #Shionogi #SLC6A19 #ThirdRockVentures #VertexPharmaceuticals
https://www.europesays.com/france/64097/

https://www.europesays.com/ch/102138/ Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC #Alzheimer’sAssociation #Alzheimer'sDisease #BloodTest #BloodTests #Elecsys #FeaturedResearchSession #Genentech #OralPresentations #Roche #RocheGroup

https://www.europesays.com/ch/101854/ Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC #Alzheimer’sAssociation #Alzheimer'sDisease #BloodTest #BloodTests #Elecsys #FeaturedResearchSession #Genentech #OralPresentations #Roche #RocheGroup

https://www.europesays.com/ch/99568/ Genentech Enspryng cuts MOGAD relapse risk 68% #68%RelapseReduction #AutoimmuneDisease #ENSPRYNG #Genentech #MOGAD #PhaseIIITrial #RHHBY #Roche #satralizumab

https://www.europesays.com/ch/98715/ Genentech, Roche line up 18 AAIC Alzheimer’s data #AAIC #Alzheimer'sDisease #diagnostics #ElecsysPTau217 #Genentech #RHHBY #Roche #trontinemab

https://www.europesays.com/ch/98305/ Genentech cuts more than 100 jobs after nearly 500 layoffs last year #AvivRegev #BiotechLayoffs #BiotechResearch #BiotechnologyIndustry #DrugDiscovery #Genentech #GenentechLayoffs #GenentechResearchAndEarlyDevelopment #gRED #HealthcareIndustry #LifeSciences #ManWahTan #PharmaceuticalJobs #ResearchRestructuring #Roche #RocheLayoffs #SouthSanFrancisco #ToddMcDevitt #VishvaDixit #WorkforceReduction

https://www.europesays.com/ch/98137/ Roche pens $490m Astex breast cancer license deal #AstexPharmaceuticals #BloodCancer #BreastCancer #cancer #CancerResearchHorizons #CancerResearchUK #DrugDiscovery #Genentech #LicensingDeal #Roche

https://www.europesays.com/ch/90908/ Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors #and #Appoints #Biotherapeutics #board #Calidi #Celgene #Corsee #Directors; #executive #former #Genentech/Roche #of #PhD #Roche #Sanders #to

https://www.europesays.com/ch/90646/ Calidi names Corsee Sanders to board #biotechnology #BoardAppointment #CalidiBiotherapeutics #Celgene #CLDI #CorseeSanders #Genentech #Roche

https://www.europesays.com/ch/90330/ Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration #ClinicalDevelopment #DrugDiscovery #Genentech #news #RNAInterference #Roche #sanegenebio #ShareholderLawsuit

https://www.europesays.com/ch/87155/ Roche breaks ground on $700M manufacturing site in N.C. #DonaldTrump #DrugManufacturing #FiercePharmaHomepage #Genentech #investment #NorthCarolina #ObesityDrugs #Pharma #Roche

https://www.europesays.com/ch/86580/ Roche’s Genentech cleared for massive headquarters expansion that will add up to 4.3M square feet #expansion #facilities #FiercePharmaHomepage #Genentech #headquarters #Pharma #Roche

https://www.europesays.com/ch/86462/ Gilead gives pink slips to 149, while Roche cuts 108 in Bay Area #FiercePharmaHomepage #Genentech #GileadSciences #Layoffs #Pharma #Roche

https://www.europesays.com/ch/85633/ Genentech pens $420M deal for Omass’ preclinical IBD program #biotech #Deals #FierceBiotechHomepage #Genentech #InflammatoryBowelDisease #LicensingDeals #OMassTherapeutics #Roche

https://www.europesays.com/ch/82403/ Bicycle lays off staff as Genentech rides away from R&D pact #BicycleTherapeutics #biotech #Deals #FierceBiotechHomepage #Genentech #ImmunoOncology #Layoffs #Roche

https://www.europesays.com/ch/81875/ Genentech scraps $2B cell therapy pact #AdaptiveBiotechnologies #biotech #CancerDrugs #Cell&GeneTherapy #Deals #DevelopmentDeals #FierceBiotechHomepage #Genentech #LicensingDeals #PersonalizedMedicine #Roche

https://www.europesays.com/ch/81867/ Roche sees Alnylam RNAi drug flunk trial, still plans phase 3 #AlnylamPharmaceuticals #biotech #ClinicalData #FailedTrials #FierceBiotechHomepage #Genentech #hypertension #Roche

https://www.europesays.com/ch/81757/ 3 Genetech VPs among those dismissed in another round of layoffs #biotech #BiotechLayoffs #FierceBiotechHomepage #FiercePharmaHomepage #Genentech #Layoffs #Roche

https://www.europesays.com/ch/81711/ Eye disease biotech launches with $100M, Roche rival in clinic #AgeRelatedMacularDegeneration #biotech #BiotechVentureCapital #EyeDisease #FierceBiotechHomepage #fundraising #Genentech #ophthalmology #Roche #Startups #VentureCapital

https://www.europesays.com/ch/81505/ Dealmaking flurry continues with Genentech-Caris collab #biotech #BiotechDeals #CarisLifeSciences #Deals #discovery #FierceBiotechHomepage #Genentech #LicensingDeals #medtech #research #Roche

https://www.europesays.com/ch/81320/ Roche reports pivotal MS win, but deaths add to safety questions #Aubagio #biotech #BTKInhibitors #ClinicalData #FierceBiotechHomepage #Genentech #MultipleSclerosis #Roche

Health organizations attacking Trump's Tylenol-autism claims are cozied up with Big Pharma

https://web.brid.gy/r/https://www.theblaze.com/news/health-organizations-attacking-trump-s-tylenol-autism-claims-are-cozied-up-with-big-pharma

#Genentech employee shuttle: here’s what we do, here’s our podcast

#Apple / #Google shuttles: run silent run deep, please don’t egg us

#Genentech employee shuttle: here’s what we do, here’s our podcast

#Apple / #Google shuttles: run silent run deep, please don’t egg us

🔍 Explore Advanced Data Visualization Techniques!

👨‍💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!

🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package

#RStats #DataScience #Webinar #Genentech #ggsurvfit

🔍 Explore Advanced Data Visualization Techniques!

👨‍💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!

🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package

#RStats #DataScience #Webinar #Genentech #ggsurvfit

🔍 Explore Advanced Data Visualization Techniques!

👨‍💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!

🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package

#RStats #DataScience #Webinar #Genentech #ggsurvfit

http://bit.ly/3H1BGIT
Yesterday, The #Stanford Daily
echoed Dec.18 retraction of paper by its former president Marc Tessier-Lavigne pub in journal #Nature in 2009
Since 2012 it has been known that its claimed groundbreaking finding about #Alzheimer's disease was a fraud that boosted #GenenTech stock

http://bit.ly/3H1BGIT
Yesterday, The #Stanford Daily
echoed Dec.18 retraction of paper by its former president Marc Tessier-Lavigne pub in journal #Nature in 2009
Since 2012 it has been known that its claimed groundbreaking finding about #Alzheimer's disease was a fraud that boosted #GenenTech stock

Amgen-Horizon merger clearance a setback to FTC's antitrust enforcement plans -- Genentech sees more potential in peptides, signs $1B biobucks deal with PeptiDream -- FDA rejects nasal spray for severe allergic reactions -- See more on our front page news http://bit.ly/w28kSd #amgen #ftc #antitrust #mergersandacquisitions #genentech #peptides #biobucks #fda #allergicreactions #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

FTC scrutiny chills medtech M&A market — Pfizer inks manufacturing deals with Samsung Biologics worth nearly $900M -- Genentech starting to adopt menopause benefits as they work on recruiting and retaining female employees -- See more on our front page news http://bit.ly/w28kSd #ftc #medtech #mergersandacquistions #antitrust #pfizer #samsung #drugmanufacturing #genentech #menopause #employees #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

"In 2009, Marc Tessier-Lavigne, then a top executive at the biotechnology company #Genentech, was the primary author of a #scientific paper published in the prestigious journal Nature that claimed to have found the potential cause for brain degeneration in #Alzheimer’s patients.
[…] Neither a correction nor a retraction was issued, and the paper stands to this day."

Impressive investigation by #TheoBaker: https://stanforddaily.com/2023/02/17/internal-review-found-falsified-data-in-stanford-presidents-alzheimers-research-colleagues-allege/ #medicines #authorship #science #historyOfScience #ethics 🧶

"In 2009, Marc Tessier-Lavigne, then a top executive at the biotechnology company #Genentech, was the primary author of a #scientific paper published in the prestigious journal Nature that claimed to have found the potential cause for brain degeneration in #Alzheimer’s patients.
[…] Neither a correction nor a retraction was issued, and the paper stands to this day."

Impressive investigation by #TheoBaker: https://stanforddaily.com/2023/02/17/internal-review-found-falsified-data-in-stanford-presidents-alzheimers-research-colleagues-allege/ #medicines #authorship #science #historyOfScience #ethics 🧶

"In 2009, Marc Tessier-Lavigne, then a top executive at the biotechnology company #Genentech, was the primary author of a #scientific paper published in the prestigious journal Nature that claimed to have found the potential cause for brain degeneration in #Alzheimer’s patients.
[…] Neither a correction nor a retraction was issued, and the paper stands to this day."

Impressive investigation by #TheoBaker: https://stanforddaily.com/2023/02/17/internal-review-found-falsified-data-in-stanford-presidents-alzheimers-research-colleagues-allege/ #medicines #authorship #science #historyOfScience #ethics 🧶

My latest clinical pipeline column for @NatureMedicine is out today.
It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody
for relapsed or refractory follicular #lymphoma.

#FollicularLymphoma #Hematology #MonoclonalAntibody #DrugDevelopment

https://www.nature.com/articles/d41591-023-00010-0

My latest clinical pipeline column for @NatureMedicine is out today.
It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody
for relapsed or refractory follicular #lymphoma.

#FollicularLymphoma #Hematology #MonoclonalAntibody #DrugDevelopment

https://www.nature.com/articles/d41591-023-00010-0

#COVID NEWS (USA)

#FDA approved a new indication for the #monoclonal #antibody tocilizumab (Actemra, #Genentech) for treatment of hospitalized adults with #COVID19 receiving systemic corticosteroids and requiring supplement oxygen, mechanical ventilation (invasive or non-invasive), or #ECMO.

https://www.fda.gov/media/150319/download

#COVID NEWS (USA)

#FDA approved a new indication for the #monoclonal #antibody tocilizumab (Actemra, #Genentech) for treatment of hospitalized adults with #COVID19 receiving systemic corticosteroids and requiring supplement oxygen, mechanical ventilation (invasive or non-invasive), or #ECMO.

https://www.fda.gov/media/150319/download

#COVID NEWS (USA)

#FDA approved a new indication for the #monoclonal #antibody tocilizumab (Actemra, #Genentech) for treatment of hospitalized adults with #COVID19 receiving systemic corticosteroids and requiring supplement oxygen, mechanical ventilation (invasive or non-invasive), or #ECMO.

https://www.fda.gov/media/150319/download

Hot off the press: in vivo active SMARCA2 degraders, courtesy of a joint effort between my #Arvinas colleagues and collaborators at #Genentech.
https://www.nature.com/articles/s41467-022-34562-5